bioAffinity Technologies, Inc (BIAF)
NCM · Common · CUSIP 09076W109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BIAF and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09076W109
Market Cap
Micro Cap
IPO
9/1/2022 · $6.125/unit
Business: bioAffinity Technologies, Inc develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state.

Company Contact

CEO
Maria Zannes
CFO
J. Michael Edwards
Headquarters
22211 W Interstate 10, Suite 1206, San Antonio, TX 78257
Phone
210-698-5334
Investor Relations
Dave Gentry, RedChip Companies Inc. · 800-733-2447 · BIAF@redchip.com
General Email
info@bioaffinitytech.com
SEC EDGAR Filings
View filings »